SPOTLIGHT -
Psychiatric Comorbidities in Epilepsy: Implications for Clinical Practice
Psychiatric disorders affect 1 in 3 individuals with epilepsy—and their etiology is multifactorial.
I Revealed That I Take Medication for My Mental Health to Millions Online. Here’s What Happened.
"When I was very young and dreaming of becoming a doctor, I never witnessed a physician open up about their mental health, let alone admit to taking medication for it..."
The Mental State of Our Union
How did the President address mental health in his State of the Union address?
Perspectives on Excited Delirium and Ketamine
Parenteral ketamine is commonly used to manage agitation that is deemed severe and obstructive to necessary medical evaluation and treatment. But what does this suggest about the relationship between medicine and society?
Before the Toils of War: Mental Health in Ukraine
The mental health of Ukrainians is essential, now more than ever.
A Hole in a Sleeve
A subtle, yet inspirational lesson of helping others with dignity and respect.
Psychiatry and the Psychodynamics of Societal Paranoia
Can psychiatry play a constructive role in understanding societies where conspiracy theories flourish?
Acknowledging the Great Women in Our Lives
What woman inspires you?
We Should Have a Unique Opportunity to Address 2 Major Dangers to Humanity
Nuclear war and climate instability driven by a desire for power and money.
Study Connects Key Neural Mechanism to Bulimia Nervosa
Findings show relationship between binge eating and brain activation.
Study Intends to Find New Ways to Treat or Prevent Major Depression
Investigators have launched a 3-year study to develop predictive models that will help identify better treatment plans for patients with depression.
Remember the Alamo: Watching a Wired War
We must not allow what happened at the Alamo to happen to Ukraine.
In Case You Missed It: February 2022
Psychiatric Times featured a wide variety of psychiatric issues and current events throughout February.
From the Pages of Psychiatric Times: February 2022
The experts weighed in on a wide variety of psychiatric issues for the Psychiatric Times February 2022 issue.
Dehumanization
A psychiatrist's thoughts and reflections after the week's news.
New Co-Trustee Named for the Sigourney Award
The Trust renews its commitment to the field of psychoanalysis with this new appointment.
Writing for General Readers
“Most people say that pretty much all physicians have a book inside them—and I agree.”
Need Your Sleep: DTx for Treating Comorbid Insomnia and Psychiatric Disorders
Digital therapeutics may be poised to step up as the next CBT.
Advocating for the Advocates
Mental health providers advocate for others—but what about for themselves?
Older Adults’ Attitudes on Mental Health Care
Respondents discussed COVID-19 conditions and mental health benefits.
New Study Finds Some Resilience, Some Burnout in Health Care Workers
Mixed results from recent study of health care workers. What does it all mean?
Helping Patients With Attentional Difficulties and Maladaptive Use of Psychoactive Substances
How can psychopharmacologists effectively (and safely) prescribe stimulants to patients with ADHD who may be using psychoactive substances?
Fighting Frontal Fatigue
New book explores the effects of modern life and technology on mental illness.
What Would Dr Post Say About President Putin?
The Ukrainian invasion has begun. What does this say of Putin?
Researchers Address Youth Suicide Prevention in Virtual Panel
Panelists presented 2 studies comparing evidence-based strategies for improved patient outcomes.
New Directions for Insomnia and Bipolar Disorder
The average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.
Our Own Deteriorating Mental Wellness
The state of US mental health may be poor, but what about psychiatrists specifically?
A Simple Concept With Complex Implications
Comorbidity: The concept is simple enough, but in practice, comorbidity drives complexity and presents the specters of diagnostic ambiguity and therapeutic unpredictability.
Brain Capital: An Emerging Investment Opportunity
Brain Capital: a fresh approach to technologies and investing.
New sNDA Submitted to FDA for Major Depressive Disorder
If approved, this will be the fourth indication for the drug, joining its approvals for episodes associated with bipolar I disorder and schizophrenia.